DJIA 15,112.19 -206.04 -1.35%
NASDAQ 3,443.20 -38.98 -1.12%
S&P 500 1,628.93 -22.88 -1.39%
market minute promo

XenoPort, Inc.

NASDAQ: XNPT

5.29 -0.14 (-2.58%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

XNPT $5.29 -2.58%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $5.41
Previous Close $5.43
Daily Range $5.22 - $5.43
52-Week Range $4.93 - $12.98
Market Cap $250.8M
P/E Ratio -5.32
Dividend (Yield) $0.00 (0.0%)
Volume 409,820
Average Daily Volume 592,344
Current FY EPS -$1.86

Sector

Healthcare

Industry

Drugs

XenoPort, Inc. (XNPT) Description

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. Website: http://www.xenoport.com/

News & Commentary Rss Feed

Does Restless Legs Syndrome Really Shorten Life Span?

A new study suggests a link between this neurological disorder and mortality rates in men.

Mid-Day Update: Benzinga's Top Downgrades

XenoPort to Present at the Wells Fargo Securities Healthcare Conference

UPDATE: Morgan Stanley Downgrades XenoPort on Recent Failures

XenoPort Announces New Employment Inducement Awards

Oversold Conditions For XenoPort (XNPT)

This Week in Biotech

Taking a page out of the old West, it was a mix of the good, the bad, and the ugly this week in the biotech sector.

XenoPort Resumes Horizant Supply - Analyst Blog

XenoPort Candidate Disappoints - Analyst Blog

UPDATE: Deutsche Bank Reiterates Buy, Lowers PT on XenoPort on Disappointing Results

See More XNPT News...

XNPT's Top Competitors

XNPT $5.29 (-2.58%)
Current stock: XNPT
JNJ $84.86 (-1.74%)
Current stock: JNJ
NVS $71.90 (-1.67%)
Current stock: NVS
RHHBY $61.90 (-0.88%)
Current stock: RHHBY